Re­searchers de­tail da­ta from first 15 au­toim­mune dis­ease pa­tients treat­ed with CAR-T — and out­stand­ing ques­tions

The team of Ger­man re­searchers who first re­port­ed clin­i­cal da­ta back­ing the idea of us­ing CAR-T cell ther­a­pies to treat au­toim­mune dis­or­ders has spelled out more gran­u­lar in­for­ma­tion on pa­tients who have re­ceived the treat­ment.

The pub­li­ca­tion of their lat­est find­ings in the New Eng­land Jour­nal of Med­i­cine fol­lows a pre­sen­ta­tion at the Amer­i­can So­ci­ety of Hema­tol­ogy an­nu­al meet­ing in De­cem­ber. At the time, they re­port­ed that all 15 pa­tients who re­ceived CAR-T at their hos­pi­tal saw the de­bil­i­tat­ing symp­toms of their dis­eases sub­stan­tial­ly im­prove or go away en­tire­ly.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER